(Date:1/8/2009)... Brain perfusion applicati...rprise using the Ziostation® thin-client syste...(PRWEB) January 8, 2009 -- Ziosoft®, Inc. , a...tware for medical imaging , today announced that ...d and Drug Administration (FDA) for its CT brain p...
(Date:1/7/2009)..., SOUTH BEND, Ind., Jan. 8 Pr... acquired PatientFlow Technology (PatientFlow), a,... and services for hospitals.,The Boston-based com...by,offering strategic solutions for patient flow ...wait times, bumped or delayed surgeries, and lack ...
(Date:1/7/2009)... NORCROSS, Ga., Jan. 7 Immucor, Inc.,(Nasdaq: ...nstrument-reagent,systems to the blood transfusion...e fiscal second quarter ended November 30, 2008. ,... fiscal second quarter of 2009 was $73.0 million, ...year. , -- Gross margin was 73.3% in the quart...
(Date:1/7/2009)... INDIANAPOLIS, Jan. 7 WellPoint, Inc. (NYSE: ...cheduled to present at the 27th Annual J.P.,Morgan....m. Pacific Standard,Time (12:30 p.m. Eastern Stan...release earnings results for the three,months ende...nc. is currently,in a quiet period prior to this s...
Breaking Medicine News(10 mins):Health News:Ziosoft Receives FDA Clearance for CT Brain Perfusion Application 2Health News:Press Ganey Acquires PatientFlow Technology 2Health News:Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance 2Health News:Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance 3Health News:Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance 4Health News:Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance 5Health News:Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance 6Health News:Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance 7Health News:Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance 8Health News:Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance 9Health News:WellPoint Announces Appearance at Upcoming Conference 2(Date:12/27/2008)...S, Bermuda, Dec. 23 Warn...day that one of its subsidiaries and Mayne Pharma ... Hospira, Inc., have filed lawsuits against each o...Mylan Pharmaceuticals Inc. ("Mylan") and Impax Lab...or the District of New Jersey for infringement of ...
(Date:12/27/2008)...oisselier breaks 5-year silence, offers to ease cl...ic , , LAS VEGAS, Dec. 27 /PRNewswire-USNewswir... Eve, the first cloned child, Dr. Brigitte Boissel...oject, said Eve and other babies cloned by her com...no one invading their families, privacy. , , "W...
(Date:12/17/2008)...tists show for the first time that normal stem cel... tissues , , MEMPHIS, Tenn., Dec. 17 /PRNew...dren,s Research Hospital have answered a central q...ls can give rise to tumors. Stem cells are immatur... mature differentiated cells that compose the rang...
(Date:12/17/2008)...if., Dec. 17 PEAK Surgical, Inc., ... tissue dissection system based on a,proprietary ... Drug,Administration (FDA) has granted the compan...System for cutting and coagulation of soft tissue ... and throat), gynecologic,orthopedic, arthroscop...
Breaking Medicine Technology:Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3'We're Ready to Prove It!' 2Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 2Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4Sagent Pharmaceuticals Launches Ceftriaxone USP and Cefuroxime for Injection USP 6579 1Sagent Pharmaceuticals Launches Ceftriaxone USP and Cefuroxime for Injection USP 6579 2Sagent Pharmaceuticals Launches Ceftriaxone USP and Cefuroxime for Injection USP 6579 3Huifeng Bio pharmaceutical Technology Inc Announces Strategic Alliance with Premier Media Service Inc 6574 1Huifeng Bio pharmaceutical Technology Inc Announces Strategic Alliance with Premier Media Service Inc 6574 2Huifeng Bio pharmaceutical Technology Inc Announces Strategic Alliance with Premier Media Service Inc 6574 3University of Miami Miller School of Medicine Becomes a GeneGo Center of Excellence 6572 1University of Miami Miller School of Medicine Becomes a GeneGo Center of Excellence 6572 2Worlds Top 20 Pharmaceutical Companies Deploy Revolutionary H Cube 28R 29 From ThalesNano Inc 6569 1Worlds Top 20 Pharmaceutical Companies Deploy Revolutionary H Cube 28R 29 From ThalesNano Inc 6569 2...tudy published today in the,journal Current Medica...escitalopram) was superior to Cymbalta®,(dulox...or,depressive disorder (MDD) and was at least as e...tly compared Cipralex® (an,allosteric serotoni...tonin and noradrenaline reuptake inhibitor - SNRI)...
...2007 - Introgen Therapeutics, Inc.,(NASDAQ: INGN) ...orted updated Phase 2 data demonstrating a signifi...nses and increased,survival following ADVEXIN(R) t...rcinoma of the head and neck. The data (Abstract,#...f the American,Society of Clinical Oncology in Chi...
Other Medicine Technology:Cipralex demonstrates superiority to duloxetine for acute treatment,of depression in new study 2Cipralex demonstrates superiority to duloxetine for acute treatment,of depression in new study 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4...The Roche CARDIAC proBNP assay is a rapid and accu...er system assisting the diagnosis and assessment o...., ,As excellence is both speed and accuracy ...e Roche CARDIAC proBNP assay = 12 minutes. In emer...
Intermittent catheter
...Welcome to a new dimension in vitreoretinal surger...of purified perfluoro-n-octane, you can greatly ex...al for managing retinal detachments complicated by...ars and trauma. , ,Certified to be >99.9 perce...
Disease diagnosis and treatment reference sourced from Griffith's 5-Minute Clinical Consult. Save time diagnosing and treating more than 1,200 diseases and conditions.
Medicine Products: